Trial Profile
Phase II trial of histone-H1-3 (OncoHist) in patients with refractory acute myeloid leukaemia and non-Hodgkin's lymphoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Nov 2014
Price :
$35
*
At a glance
- Drugs Histone H1-3 (Primary) ; Cytarabine; Mitoxantrone
- Indications Acute myeloid leukaemia; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Acronyms ARAHIST-90
- Sponsors SymbioTec
- 07 Jul 2010 New trial record